Matthew Alessandri

Matthew Alessandri has over 30 years of experience in the biotechnology and healthcare industries. Currently, they are the Vice President of Pharma Business Development at Nucleai since September 2022. Prior to this, they worked at Invicro, A Konica Minolta Company, where they served as the Vice President of Business Development for Advanced Pathology Services from May 2018 to September 2022. Earlier in their career, Matthew held various positions at companies such as Covance, Ambry Genetics, SciGene, Cogenics, Millipore Corporation, Roche Diagnostics, Baxter Healthcare, and Schleicher & Schuell. Matthew'sroles encompassed business development, sales, and management in the field of genomics and diagnostics.

Matthew Alessandri attended Providence College from 1985 to 1989, where they obtained a Bachelor of Science degree in Biology.